For the Inventor, By the Inventor

Enter assignee name

Gaithersburg, MD, United States of America

Lentigen Technology, Inc.

USPTO Granted Patents = 37

CIPO Patents = 4

EPO Patents = 7

Forward Citations = 66

Loading Chart...

Loading Chart...

19 inventors (with patents filed for the assignee):

Dina Schneider (37 out of 37 patents)

Boro Dropulic (36 out of 47 patents)

Rimas J Orentas (32 out of 42 patents)

4. Zhongyu Zhu (18 out of 50 patents)

5. Dimiter Stanchev Dimitrov (15 out of 97 patents)

6. Stefan Miltenyi (5 out of 61 patents)

7. Waleed M Haso (5 out of 5 patents)

8. Peirong Hu (4 out of 4 patents)

9. Bang Khoa Vu (2 out of 2 patents)

10. Leah Marie Alabanza (2 out of 2 patents)

11. Kim Anthony Gonda (2 out of 2 patents)

12. Winfried Krueger (2 out of 2 patents)

13. Terry James Fry (1 out of 1 patent)

14. Florian Tomszak (1 out of 1 patent)

15. Rafijul Bari (1 out of 1 patent)

37 patents: Sort by Forward Citations

1. 12391958 - Compositions and methods for treating cancer with anti-CD38 immunotherapy (2025-08-19),

2. 12391740 - Compositions and methods for treating cancer with anti-BCMA immunotherapy (2025-08-19),

3. 12371490 - Compositions and methods for treating cancer with anti-CD19/CD22 immunotherapy (2025-07-29),

4. 12365718 - Compositions and methods for treating cancer with DuoCARs (2025-07-22),

5. 12193995 - Method to treat cancer with engineered T-cells (2025-01-14),

6. 12122831 - Compositions and methods for treating cancer with anti-CD19/CD22 immunotherapy (2024-10-22),

7. 12037403 - Compositions and methods for treating cancer with anti-CD123 immunotherapy (2024-07-16),

8. 12024554 - Compositions and methods for treating HIV/AIDS with immunotherapy (2024-07-02),

9. 11970528 - Compositions and methods for treating cancer with anti-mesothelin immunotherapy (2024-04-30),

10. 11969443 - Compositions and methods for treating cancer with self-driving chimeric antigen receptors (2024-04-30),

11. 11905515 - Chimeric antigen receptors and methods of use (2024-02-20),

12. 11878052 - Compositions and methods for treating cancer with anti-CD22 immunotherapy (2024-01-23),

13. 11802142 - Compositions and methods for treating cancer with DuoCARs (2023-10-31),

14. 11708408 - Compositions and methods for treating cancer with anti-CD19 immunotherapy (2023-07-25),

15. 11680103 - Compositions and methods for treating cancer with anti-CD19/CD20 immunotherapy (2023-06-20),

Lentigen Technology, Inc. is a biotechnology company specializing in the development and manufacturing of lentiviral vectors for gene and cell therapy applications. With extensive experience and cutting-edge technology, Lentigen provides innovative solutions for the delivery of genes into cells, enabling the development of advanced therapies for various diseases. Located in Maryland, Lentigen serves the biotech and pharmaceutical industries, academic institutions, and research organizations worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

37 Patents

#10 in Gaithersburg, MD

#102 in Maryland

#8,939 in US

#17,697 in the World

Gaithersburg, MD, United States of America

Lentigen Technology, Inc.

Forward Citations = 66

19 inventors:

Dina Schneider (37 out of 37 patents)

Boro Dropulic (36 out of 47 patents)

Rimas J Orentas (32 out of 42 patents)

4. Zhongyu Zhu (18 out of 50 patents)

5. Dimiter Stanchev Dimitrov (15 out of 97 patents)

Please report any incorrect information to support@idiyas.com

Loading…